Panbela Therapeutics, Inc. (PBLA) Misses Q2 EPS by $1.25
Tweet
Share
E-mailGet Alerts PBLA Hot Sheet
Join SI Premium – FREE
Panbela Therapeutics, Inc. (NASDAQ: PBLA) reported Q2 EPS of ($1.51), $1.25 worse than the analyst estimate of ($0.26).
For earnings history and earnings-related data on Panbela Therapeutics, Inc. (PBLA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
- Planet Labs (PL) Tops Q2 EPS by 4c, Offers Guidance
- Samsara Inc (IOT) Tops Q2 EPS by 4c, Beats on Revenue; Offers Q3 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
